BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 15913603)

  • 1. Expression of the transient receptor potential vanilloid 1 (TRPV1) in LNCaP and PC-3 prostate cancer cells and in human prostate tissue.
    Sanchez MG; Sanchez AM; Collado B; Malagarie-Cazenave S; Olea N; Carmena MJ; Prieto JC; Diaz-Laviada I I
    Eur J Pharmacol; 2005 May; 515(1-3):20-7. PubMed ID: 15913603
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cloning and pharmacological characterization of mouse TRPV1.
    Correll CC; Phelps PT; Anthes JC; Umland S; Greenfeder S
    Neurosci Lett; 2004 Nov; 370(1):55-60. PubMed ID: 15489017
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 5-Iodoresiniferatoxin evokes hypothermia in mice and is a partial transient receptor potential vanilloid 1 agonist in vitro.
    Shimizu I; Iida T; Horiuchi N; Caterina MJ
    J Pharmacol Exp Ther; 2005 Sep; 314(3):1378-85. PubMed ID: 15947039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Characterization of SB-705498, a potent and selective vanilloid receptor-1 (VR1/TRPV1) antagonist that inhibits the capsaicin-, acid-, and heat-mediated activation of the receptor.
    Gunthorpe MJ; Hannan SL; Smart D; Jerman JC; Arpino S; Smith GD; Brough S; Wright J; Egerton J; Lappin SC; Holland VA; Winborn K; Thompson M; Rami HK; Randall A; Davis JB
    J Pharmacol Exp Ther; 2007 Jun; 321(3):1183-92. PubMed ID: 17392405
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cloning and functional characterization of dog transient receptor potential vanilloid receptor-1 (TRPV1).
    Phelps PT; Anthes JC; Correll CC
    Eur J Pharmacol; 2005 Apr; 513(1-2):57-66. PubMed ID: 15878709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular cloning, functional characterization of the porcine transient receptor potential V1 (pTRPV1) and pharmacological comparison with endogenous pTRPV1.
    Ohta T; Komatsu R; Imagawa T; Otsuguro K; Ito S
    Biochem Pharmacol; 2005 Dec; 71(1-2):173-87. PubMed ID: 16288992
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TRPV3 is a temperature-sensitive vanilloid receptor-like protein.
    Smith GD; Gunthorpe MJ; Kelsell RE; Hayes PD; Reilly P; Facer P; Wright JE; Jerman JC; Walhin JP; Ooi L; Egerton J; Charles KJ; Smart D; Randall AD; Anand P; Davis JB
    Nature; 2002 Jul; 418(6894):186-90. PubMed ID: 12077606
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transient receptor potential vanilloid-1-mediated calcium responses are inhibited by the alkylamine antihistamines dexbrompheniramine and chlorpheniramine.
    Sadofsky LR; Campi B; Trevisani M; Compton SJ; Morice AH
    Exp Lung Res; 2008 Dec; 34(10):681-93. PubMed ID: 19085565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms involved in potentiation of transient receptor potential vanilloid 1 responses by ethanol.
    Vetter I; Wyse BD; Roberts-Thomson SJ; Monteith GR; Cabot PJ
    Eur J Pain; 2008 May; 12(4):441-54. PubMed ID: 17826200
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of apoptosis in prostate tumor PC-3 cells and inhibition of xenograft prostate tumor growth by the vanilloid capsaicin.
    Sánchez AM; Sánchez MG; Malagarie-Cazenave S; Olea N; Díaz-Laviada I
    Apoptosis; 2006 Jan; 11(1):89-99. PubMed ID: 16374544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A-425619 [1-isoquinolin-5-yl-3-(4-trifluoromethyl-benzyl)-urea], a novel and selective transient receptor potential type V1 receptor antagonist, blocks channel activation by vanilloids, heat, and acid.
    El Kouhen R; Surowy CS; Bianchi BR; Neelands TR; McDonald HA; Niforatos W; Gomtsyan A; Lee CH; Honore P; Sullivan JP; Jarvis MF; Faltynek CR
    J Pharmacol Exp Ther; 2005 Jul; 314(1):400-9. PubMed ID: 15837819
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vanilloid receptor agonists and antagonists are mitochondrial inhibitors: how vanilloids cause non-vanilloid receptor mediated cell death.
    Athanasiou A; Smith PA; Vakilpour S; Kumaran NM; Turner AE; Bagiokou D; Layfield R; Ray DE; Westwell AD; Alexander SP; Kendall DA; Lobo DN; Watson SA; Lophatanon A; Muir KA; Guo DA; Bates TE
    Biochem Biophys Res Commun; 2007 Mar; 354(1):50-5. PubMed ID: 17214968
    [TBL] [Abstract][Full Text] [Related]  

  • 13. (R)-(5-tert-butyl-2,3-dihydro-1H-inden-1-yl)-3-(1H-indazol-4-yl)-urea (ABT-102) blocks polymodal activation of transient receptor potential vanilloid 1 receptors in vitro and heat-evoked firing of spinal dorsal horn neurons in vivo.
    Surowy CS; Neelands TR; Bianchi BR; McGaraughty S; El Kouhen R; Han P; Chu KL; McDonald HA; Vos M; Niforatos W; Bayburt EK; Gomtsyan A; Lee CH; Honore P; Sullivan JP; Jarvis MF; Faltynek CR
    J Pharmacol Exp Ther; 2008 Sep; 326(3):879-88. PubMed ID: 18515644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of human TRPV1 receptor activity by extracellular protons and host cell expression system.
    Bianchi BR; Lee CH; Jarvis MF; El Kouhen R; Moreland RB; Faltynek CR; Puttfarcken PS
    Eur J Pharmacol; 2006 May; 537(1-3):20-30. PubMed ID: 16630609
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Binding of [(3)H]A-778317 to native transient receptor potential vanilloid-1 (TRPV1) channels in rat dorsal root ganglia and spinal cord.
    Bianchi BR; El Kouhen R; Chen J; Puttfarcken PS
    Eur J Pharmacol; 2010 May; 633(1-3):15-23. PubMed ID: 20153316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional transient receptor potential vanilloid 1 is expressed in human urothelial cells.
    Charrua A; Reguenga C; Cordeiro JM; Correiade-Sá P; Paule C; Nagy I; Cruz F; Avelino A
    J Urol; 2009 Dec; 182(6):2944-50. PubMed ID: 19846148
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Activation of transient receptor potential vanilloid type-1 channel prevents adipogenesis and obesity.
    Zhang LL; Yan Liu D; Ma LQ; Luo ZD; Cao TB; Zhong J; Yan ZC; Wang LJ; Zhao ZG; Zhu SJ; Schrader M; Thilo F; Zhu ZM; Tepel M
    Circ Res; 2007 Apr; 100(7):1063-70. PubMed ID: 17347480
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thermo-sensitive transient receptor potential vanilloid channel-1 regulates intracellular calcium and triggers chromogranin A secretion in pancreatic neuroendocrine BON-1 tumor cells.
    Mergler S; Skrzypski M; Sassek M; Pietrzak P; Pucci C; Wiedenmann B; Strowski MZ
    Cell Signal; 2012 Jan; 24(1):233-46. PubMed ID: 21945155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transient receptor potential vanilloid 1 (TRPV1) channels in cultured rat Sertoli cells regulate an acid sensing chloride channel.
    Auzanneau C; Norez C; Antigny F; Thoreau V; Jougla C; Cantereau A; Becq F; Vandebrouck C
    Biochem Pharmacol; 2008 Jan; 75(2):476-83. PubMed ID: 17945192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [3H]A-778317 [1-((R)-5-tert-butyl-indan-1-yl)-3-isoquinolin-5-yl-urea]: a novel, stereoselective, high-affinity antagonist is a useful radioligand for the human transient receptor potential vanilloid-1 (TRPV1) receptor.
    Bianchi BR; El Kouhen R; Neelands TR; Lee CH; Gomtsyan A; Raja SN; Vaidyanathan SN; Surber B; McDonald HA; Surowy CS; Faltynek CR; Moreland RB; Jarvis MF; Puttfarcken PS
    J Pharmacol Exp Ther; 2007 Oct; 323(1):285-93. PubMed ID: 17660385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.